Toward Better Understanding and Management of Solitary Fibrous Tumor

被引：18
作者：
Kazazian, Karineh [1 ]
Demicco, Elizabeth G. [2 ,3 ]
de Perrot, Marc [1 ,4 ]
Strauss, Dirk [5 ]
Swallow, Carol J. [1 ,6 ,7 ]
机构：
[1] Univ Toronto, Dept Surg, Toronto, ON, Canada
[2] Mt Sinai Hosp, Dept Pathol & Lab Med, 600 Univ Ave, Toronto, ON M5G 1X5, Canada
[3] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[4] Univ Hlth Network, Princess Margaret Canc Ctr, Div Thorac Surg, 200 Elizabeth St, Toronto, ON M5G2C4, Canada
[5] Royal Marsden NHS Fdn Trust, Royal Marsden Hosp, Dept Acad Surg, Sarcoma Unit, Fulham Rd, London SW3 6JJ, England
[6] Mt Sinai Hosp, Princess Margaret Canc Ctr, Dept Surg Oncol, Toronto, ON, Canada
[7] Mt Sinai Hosp, Sinai Hlth Syst, Room 1225,600 Univ Ave, Toronto, ON M5G 1X5, Canada
来源：
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2022年 / 31卷 / 03期
关键词：
Solitary fibrous tumor; NAB2-STAT6; Risk stratification; Prognostic factors; Surgery; Therapeutic strategies; Survival; CENTRAL-NERVOUS-SYSTEM; GIANT-CELL ANGIOFIBROMA; NAB2-STAT6 GENE FUSION; TERM-FOLLOW-UP; INTRACRANIAL HEMANGIOPERICYTOMA; MENINGEAL HEMANGIOPERICYTOMA; LIPOMATOUS HEMANGIOPERICYTOMA; RADIATION-THERAPY; RISK-ASSESSMENT; PLEURA;
D O I：
10.1016/j.soc.2022.03.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：459 / 483
页数：25
相关论文
共 139 条
  • [111] Loss of CD34 and high IGF2 are associated with malignant transformation in solitary fibrous tumors
    Schulz, Birte
    Altendorf-Hofmann, Annelore
    Kirchner, Thomas
    Katenkamp, Detlef
    Petersen, Iver
    Knoesel, Thomas
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2014, 210 (02) : 92 - 97
  • [112] Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein
    Schweizer, Leonille
    Koelsche, Christian
    Sahm, Felix
    Piro, Rosario M.
    Capper, David
    Reuss, David E.
    Pusch, Stefan
    Habel, Antje
    Meyer, Jochen
    Goeck, Tanja
    Jones, David T. W.
    Mawrin, Christian
    Schittenhelm, Jens
    Becker, Albert
    Heim, Stephanie
    Simon, Matthias
    Herold-Mende, Christel
    Mechtersheimer, Gunhild
    Paulus, Werner
    Koenig, Rainer
    Wiestler, Otmar D.
    Pfister, Stefan M.
    von Deimling, Andreas
    [J]. ACTA NEUROPATHOLOGICA, 2013, 125 (05) : 651 - 658
  • [113] Solitary Fibrous Tumors of the Head and Neck: A Multi-Institutional Clinicopathologic Study
    Smith, Steven C.
    Gooding, William E.
    Elkins, Matthew
    Patel, Rajiv M.
    Harms, Paul W.
    McDaniel, Andrew S.
    Palanisamy, Nallasivam
    Uram-Tuculescu, Cora
    Balzer, Bonnie B.
    Lucas, David R.
    Seethala, Raja R.
    McHugh, Jonathan B.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (12) : 1642 - 1656
  • [114] Intracranial meningeal hemangiopericytoma: The role of radiotherapy - Report of 29 cases and review of the literature
    Soyuer, S
    Chang, EL
    Selek, U
    McCutcheon, IE
    Maor, MH
    [J]. CANCER, 2004, 100 (07) : 1491 - 1497
  • [115] Hemangiopericytoma: A 20-year single-institution experience
    Spitz, FR
    Bouvet, M
    Pisters, PWT
    Pollock, RE
    Feig, BW
    [J]. ANNALS OF SURGICAL ONCOLOGY, 1998, 5 (04) : 350 - 355
  • [116] Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study
    Stacchiotti, S.
    Simeone, N.
    Lo Vullo, S.
    Morosi, C.
    Greco, F. G.
    Gronchi, A.
    Barisella, M.
    Collini, P.
    Zaffaroni, N.
    Dagrada, G. P.
    Frezza, A. M.
    Mariani, L.
    Casali, P. G.
    [J]. EUROPEAN JOURNAL OF CANCER, 2019, 106 : 225 - 233
  • [117] Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour
    Stacchiotti, S.
    Saponara, M.
    Frapolli, R.
    Tortoreto, M.
    Cominetti, D.
    Provenzano, S.
    Negri, T.
    Dagrada, G. P.
    Gronchi, A.
    Colombo, C.
    Vincenzi, B.
    Badalamenti, G.
    Zuco, V.
    Renne, S. L.
    Collini, P.
    Morosi, C.
    Tos, A. P. Dei
    Bello, E.
    Pilotti, S.
    Casali, P. G.
    D'Incalci, M.
    Zaffaroni, N.
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 76 : 84 - 92
  • [118] Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour
    Stacchiotti, S.
    Tortoreto, M.
    Baldi, G. G.
    Grignani, G.
    Toss, A.
    Badalamenti, G.
    Cominetti, D.
    Morosi, C.
    Dei Tos, A. P.
    Festinese, F.
    Fumagalli, E.
    Provenzano, S.
    Gronchi, A.
    Pennacchioli, E.
    Negri, T.
    Dagrada, G. P.
    Spagnuolo, R. D.
    Pilotti, S.
    Casali, P. G.
    Zaffaroni, N.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 (17) : 3021 - 3028
  • [119] Response to chemotherapy of solitary fibrous tumour: A retrospective study
    Stacchiotti, S.
    Libertini, M.
    Negri, T.
    Palassini, E.
    Gronchi, A.
    Fatigoni, S.
    Poletti, P.
    Vincenzi, B.
    Dei Tos, A. P.
    Mariani, L.
    Pilotti, S.
    Casali, P. G.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (10) : 2376 - 2383
  • [120] Sunitinib malate in solitary fibrous tumor (SFT)
    Stacchiotti, S.
    Negri, T.
    Libertini, M.
    Palassini, E.
    Marrari, A.
    De Troia, B.
    Gronchi, A.
    Dei Tos, A. P.
    Morosi, C.
    Messina, A.
    Pilotti, S.
    Casali, P. G.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (12) : 3171 - 3179
567891011121314